乳糜泻患者帕金森病风险:一项瑞典人群基础研究
基于人群匹配队列设计,研究比较瑞典活检确诊乳糜泻患者与无活检人群及未患病同胞,评估乳糜泻与帕金森病的关联。总体未见关联,但60岁前诊断乳糜泻与帕金森病发生正相关(HR=1.29;95%CI:1.02-1.62),主要归因于活检后10-15年风险显著升高(HR=1.68;95%CI:1.05-2.68)。
要点
- 总体乳糜泻与帕金森病风险无显著关联。
- 60岁前诊断乳糜泻者帕金森病风险升高(HR=1.29;95%CI:1.02-1.62)。
- 活检后10-15年帕金森病风险显著升高(HR=1.68;95%CI:1.05-2.68)。
核心结论
- 乳糜泻患者总体帕金森病风险未见显著升高,但60岁前诊断乳糜泻者长期帕金森病风险升高。
研究设计与样本
- 基于人群的匹配队列研究,比较瑞典活检确诊乳糜泻患者与无活检人群及未患病同胞。
主要发现
- 总体乳糜泻与帕金森病风险无显著关联。
- 60岁前诊断乳糜泻与帕金森病发生正相关(HR=1.29;95%CI:1.02-1.62)。
- 活检后10-15年帕金森病风险显著升高(HR=1.68;95%CI:1.05-2.68)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Using a population-based matched cohort design, we assessed the association of celiac disease (CeD) with risk of PD by comparing patients with biopsy-confirmed CeD in Sweden to a biopsy-free population and their unaffected siblings, separately. No overall association was observed but CeD diagnosed before age 60 associated positively with incident diagnosis of PD (hazard ratio [HR] = 1.29; 95% confidence interval [CI]: 1.02-1.62), which was mainly attributed to the significantly elevated risk detected after 10-15 years since biopsy (HR = 1.68; 95% CI: 1.05-2.68). Our findings imply an increased vulnerability to long-term PD development among patients with CeD diagnosed before 60s. ANN NEUROL 2023;94:911-916.
引用
- Kang X, Ploner A, Roelstraete B, et al. Risk of Parkinson's Disease in Celiac Disease: A Swedish Population-Based Study. Ann Neurol. 2023. PMID: 37632335. doi:10.1002/ana.26780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。